In this video, I review the science fiction novel "Project Hail Mary" by Andy Weir. As a fan of the genre, I was excited to dive into this action-packed and thought-provoking book that takes a critical look at some of the global issues we face today. I discuss the strengths and shortcomings of the book, as well as its potential pleasures and delights for science fiction enthusiasts. Join me as I explore the captivating story of Ryland Grace, a science teacher who wakes up alone in a spacecraft and must use his knowledge and skills to save the earth from an alien threat. Don't forget to leave a comment with your thoughts on the book and whether you would recommend it to others.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeChristian SoschnerSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome to our new series, Memorable Moments! In this series, we bring you highlights from past episodes that contain some of the most memorable insights and important information that you won't want to miss. In this episode, we explore the groundbreaking potential of AI in drug discovery and anti-aging research. Listen in as we share clips from our interview with Alex Zhavoronkov, who is leading the charge in this revolutionary technology that cuts costs, increases success rates, and drastically shortens the time it takes to develop new therapies. Join us as we share memorable moments and life-changing insights that will help you discover the incredible potential of the future of medicine. Don't miss out on this powerful and inspiring episode of our podcast - tune in now!Listen to the full episode ⏰ Timestamps00:00 Intro00:44 Alex Zhavoronkov Explains how his solution increases the probability of success, cuts costs and timelines in Drug Discovery and Development07:20 Shout out to our new subscribers on Buzzsprout+💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribeWatch on YoutubeAlex ZhavoronkovChristian SoschnerCheck out the organizations that make the podcast possibleSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you ready to dive into the future of medicine and the revolutionary advancements being made with artificial intelligence? In this episode, I sit down with Alex Zhavoronkov, the founder and CEO of Insilico Medicine, a global company focused on the discovery of novel therapeutics utilizing cutting-edge technology in healthcare.From longevity research to anti-aging treatments, Alex shares his expertise on themost impactful field of our time, discussing his work in protein targetdiscovery and the design of small molecule drugs using generative AI.But it doesn't stop there. Alex also shares insights into the development of agingclocks, biomarkers of aging, and precision medicine. Discover how generative AIis transforming the pharmaceutical industry, improving clinical trials, andproviding a revolutionary new approach to drug discovery methods.Don't miss out on this incredible opportunity to learn from one of the leadingexperts in AI and healthcare innovation. Tune in now and join us on thisfascinating journey into the future of medicine.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribeWatch on YoutubeAlex ZhavoronkovChristian SoschnerCheck out the organizations that make the podcast possible📖 Memorable quotes:(10:50) “Insilico Medicine synthesized and tested the first AI generated drug in 2017.”(23:09) “Generative AI in Drug Discovery and Drug Development has the potential to improve the probability of success by 50%”(24:00) “Generating 11 preclinical candidates in 2.5 years - is a pretty cool number.”(29:48) “We developed a clinical candidate in 18 months at a 3 million dollar cost with the help of AI. The traditional route takes 2 years at about 400 million expeonses.”(01:08:48) “Generative AI will transform our lives beyond recognition in every way.”⏰  Timestamps:(02:00) Introduction to Alex Zhavoronkov at World Government Summit 2023 (03:00) About World Government Summit 2023 (04:20) Alex's longevity research at Insilico Medicine (08:20) Accelerating drug discovery with AI (13:00) AI in synthetic biologic data (15:00) Generative AI in reducing cost and increasing output (23:30) Generative AI in increasing probability of success (25:00) Why traditional drug R&D takes over 10 years and 2 billion 2010 dollars (28:45) AI-driven drug discovery at Insilico Medicine (30:30) Insilico Medicine's pipeline and case study (38:09) Regulators' perception of AI in drug development (45:26) Generative AI in clinical development (49:15) Audience question on AI and microbiome research (53:30) Operating a company between China, Middle East, and North America (57:54) Insilico Medicine's fully automated robotics lab (01:03:15) Ageing as the most important disease in the world (01:08:00) Future impact of generative AI on medicineSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you struggling with your creative process? Do you feel stuck in a rut or blocked by perfectionism? You're not alone. In this episode, I explore the remarkable letter from artist Sol LeWitt to Eva Hesse, which has inspired creatives for decades.Not only creatives can get stuck and blocked. Also, entrepreneurs, scientists, and investors can have to face such situations in their lives. Read by Benedict Cumberbatch for Letters Live at the Freemason's Hall in London, LeWitt's timeless advice urges us to stop overthinking and DO. Embrace the process, let go of perfectionism, and believe in your ability to create. Join me as I discover the wisdom of emptiness and how it can help you unleash your full potential. From conceptual art to minimalism, I delve into the fascinating lives of Sol LeWitt and Eva Hesse, two American artists who embarked on a supportive friendship that would inspire them both. So sit back, relax, and let's listen to the words of Sol LeWitt as read by Benedict Cumberbatch. This episode is a must-listen for anyone looking to break free from creative blocks and unleash their full potential.⏰ Timestamps(00:00) Unleashing Your Creative Potential: The Remarkable Letter from Sol LeWitt to Eva Hesse Read by Benedict Cumberbatch(01:15) Background Information to Sol LeWitt, Eva Hesse, and their Inspiring Correspondence(04:00) Sol LeWitt's Timeless Advice to Eva Hesse: Stop Overthinking and Just DO(06:25) Perfectionism Kills Creativity(08:57) Embrace the Process, Don’t Focus on the Outcome(10:09) Believe in your ability to create💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeChristian SoschnerSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Do you ever wonder why it takes so long for new drugs to hit the market? Have you ever questioned the efficiency of the pharmaceutical industry?Join me in this episode as we talk to Jack Scannell, a pharmaceutical industry expert, and discover the hidden efficiency secrets of drug development. In this episode, we delve into the critical factors that have shaped drug development over the last 60 years and analyze the industry's current state.Throughout the podcast, Jack draws on his extensive industry knowledge and provides insights on the importance of decision quality, the role of AI in drug discovery, and the economics of the research model.If you're looking to gain a better understanding of the pharmaceutical industry and its inner workings, join us in uncovering the efficiency secrets of drug development. Tune in to this episode.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribeWatch on YoutubeJack ScannellChristian Soschner📖 Memorable quotes:(11:41) “Between 1950 and 2010, Drug Development saw a halving time: Every nine years, the number of drugs developed per billion dollars spent halved.”(24:58) “4 Reasons for the Decline of Drug Development Productivity: Better Than the Beatles Problem, Higher Regulatory Hurdles, Throw Money at it Problem, Misindustrialisation of Science(26:30) “Metformin is the Pharmaceutical Equivalent to the Beatles”(45:15) “In early drug discovery, predictive validity, the degree to which your model output correlates with human clinical utility is critically important”(01:19:31) “If the only tool you have to measure the height of the fruit is the rate at which you are picking fruit, and you notice that the rate of picking fruit is declining, you will always blame the low hanging fruit problem.”(01:34:15) “When capital is freely available, the average quality is going down”⏰  Timestamps:(00:00) Introduction: Uncovering Drug Development Efficiency Secrets(06:30) Background Jack Scannell: Pharma Journey(09:15) Finding erooM’s Law: Playful Experiment Leads to Discovery(12:00) Inversion of Output Efficiency: More Capital, Fewer Drugs(13:15) Best Key Figure for R&D Productivity?(20:24) Factors Behind R&D Productivity Decline - 1950 to 2010(25:30) The Beatles Inform Drug Development(28:34) The Regulatory Problem(30:00) Throwing Money at the Problem & Misindustrialisation of Science(31:00) Turnaround in Drug Development Efficiency from 2010(38:30) Speeding Up Early-Stage R&D(45:45) Technical & Managerial Components to Improve Speed(47:10) Improving Predictive Quality of Models - Alzheimer's Case Study(57:00) Interplay of Different Forces in Complex Problem Solving(01:02:30) Model Quality Matters the Most for High R&D Quality(01:12:45) Making Pharma Value Chain More Effective(01:18:00) Appropriate Success Measure for Drug R&D?(01:21:05) Role of AI in Drug Discovery Process(01:29:32) Limiting Factor of AI in Biology?(01:31:00) Availability of Capital a Limiting Factor in Drug Development?(01:39:00) Economics of Research Model - Common Goods Problem(01:47:00) Role of Public Funds to Validate R&D Model Quality(01:52:00) Truth Seeking Over Progression Seeking Behaviour: Prioritizing Scientific Integrity in Drug Development.Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Uncover the Secrets of Success with Arnold Schwarzenegger -  Mastering the 6 Rules. In this episode, join us as we delve into the mind of one of the greatest action heroes and successful entrepreneurs of our time. Arnold Schwarzenegger shares his personal experiences and lessons learned as he reveals the key elements of his famous "6 Rules for Success" speech. Get inspired and motivated as you discover the blueprint for achieving your goals and realizing your dreams.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeChristian Soschner⏰  Timestamps:(01:34) Rule #1: Have a Vision(13:12) Rule #2: Ignore the Naysayers(22:18) Rule #3: Work your A** Off(28:01) Rule #4: Don’t have a Plan B (33:38) Rule #5: Give Back(39:52) Rule #6: You Need HelpSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you curious about what it takes to be a female venture capitalist in 2023? Join us as we sit down with Jeevan, a successful woman in the industry, to discuss the world of female entrepreneurship and venture capitalism. With her insights on the tech focus areas of 2023, the challenges of attracting women into the VC world, and the importance of warm referrals, Jeevan offers a unique perspective on the startup investment landscape. Get a glimpse into the life of a female VC as she shares her journey and valuable lessons learned. Tune in now to learn what it takes to become a venture capitalist in 2023 and expand your knowledge on the exciting world of startup investments.💡 LINKS TO MORE CONTENTIf you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeJeevan SunnerChristian Soschner📖 Memorable quotes:(49:33) “Linkedin Made Investors in Silicon Valley Accessible”(49:55) “Communication, Accessibility, Relationship building, and Information sharing make social media super powerful.”(55:40) “Take your time and do your due diligence on investors to understand whether their values are aligned with yours and whether you see that 10-15 years partnership happening.”(59:30) “We are flexible in the way we collaborate with founders. It can be a more passive approach, or for first-time founders more hands-on”(01:09:00) “When it comes to dilution, we rather have a smaller slice of a bigger pie, than a massive slice of a smaller pie” ⏰  Timestamps:(00:00) Unlocking the Secrets of Venture Capital: An Insider's View (03:15) Brave the Winter of England with Jeevan in December 2022 (05:44) The Journey to Becoming a Top Venture Capitalist in 2023 (11:00) Spotting the Next Big Tech Trend in 2023 (14:20) Empowering Female Entrepreneurs and VCs to Create Change (20:00) Breaking Barriers: What it Takes to Attract More Women in Tech VC (23:00) The Power of Warm Referrals and How VCs Evaluate a Pitch deck (26:00) Timing is Everything: When is the Right Moment to Approach a VC? (30:30) A Day in the Life of a Busy Venture Capitalist (39:30) Decoding Job Titles in Venture Funds: What They Really Mean (44:15) The Human Side of Investing: Why Relationships are Key (46:15) 2 Vital Lessons for Founders from a VC's Perspective (48:55) The Rise of Social Media in the Startup Investment World 2023 (50:35) Podpower: The Importance of Podcasts in Building Relationships in 2023 (52:25) Jeevan's Must-Listen Podcast List for Entrepreneurs and Investors (56:50) Expectations Beyond Returns: What VCs Look for in Founders (01:04:30) The Investors' Role in Board Functions and Aligning Interests (01:09:50) Finding the Perfect Match: Product/Market Fit (01:13:50) Jeevan's Most Exciting Deal: Behind the Scenes (01:16:25) The Art of Closing a Deal: A VC's Perspective (01:17:55) The Challenges of Closing a Deal and the Path to Success (01:20:45) Predicting the Future of VCs: 2023 and Beyond (01:25:00) The Final Word: Jeevan's Advice for Entrepreneurs and Investors Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you ready for the grand finale of our Year in Review Recording? The final episode of 2022 is here, and it's one for the books! We've explored the cutting-edge innovations and technologies shaping the future of the biotech industry with some of the most brilliant minds in the field. From Kurt Höller of EIT Health, to Albert Missbichler from Fianostics, Caroline Heil from the new meat company, Mauricio Agudelo and Lina Toro from Bialtec, Kimberly Cornfield from the UCL, Collin Ewald from ETH Zurich, and Guido Gualdoni from G.ST Antiviral, we've had some truly enlightening conversations. But we saved the best for last! Get ready for an exclusive interview with Dr. Thomas Schubert, CEO of 2bind, a provider of biophysical outsourcing solutions that is revolutionizing the way we study molecular interactions and protein stability. Don't miss out on this one-of-a-kind episode. Tune in now! This cutting-edge biotech company is revolutionizing how we study molecular interactions and protein stability. They're doing it with a track record of over 1400 successfully completed tasks in research projects with over 350 customers in the last 11 years.In this episode, you'll get an inside look at the driving force behind 2bind and the expert knowledge that sets them apart in the biophysics field. From breakthrough moments to industry trends, you'll gain a deeper understanding of the future of biotech and the role that companies like 2bind will play in shaping it.But that's not all! You'll also hear from Dr. Schubert about the company's partnerships with leading device producers and how they navigate the digital world to stay ahead of the curve. Plus, you'll get insight into the supply chain challenges that 2bind faced in the last years and how they overcame them.Don't miss out on this opportunity to learn from the best in the business! Tune in to our latest podcast episode and join the conversation on the future of biotech.Trust us; this episode is a must-listen for anyone in the biotech industry or anyone passionate about innovation and the future of medicine. It's packed with valuable insights and information you won't miss.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Check out our partners: https://linktr.ee/lsg2Watch on YoutubeThomas SchubertChristian Soschner⏰  Timestamps:00:00) Introduction(02:00) Unveiling the mastermind behind 2bind, Dr. Thomas Schubert (04:05) Insider tips for starting your own biotech company(07:36) A glimpse into the future: 2022 for 2bind's CEO (10:40) Navigating the digital world: Pros and cons of technology in biotech (14:16) Overcoming obstacles: A look at 2bind's supply chain challenges (18:21) Game-changing developments in biophysics for 2022 (19:53) What's next for the industry? A preview of biophysics trends to come (23:19) Peeking into the crystal ball: 2bind's plans for 2023 (24:25) Mark your calendars: Upcoming conferences featuring 2bind in 2023 (30:49) Bold predictions for the biotech industry in 2023 (32:33) Addressing the challenges: How to improve drug discovery and development in 2023.Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

On this episode of "Year in Review Recording," we speak with Guido Gualdoni, Co-Founder, and CEO of G.ST Antivirals, a clinical-stage biotech company revolutionizing how we treat viral infections of the respiratory tract. Guido shares the science behind G.ST Antivirals' innovative host cell-based strategy to develop broad-spectrum antivirals and how it completely eliminates viral reproduction without the risk of resistance development. He also delves into the public funding and startup ecosystem in Vienna, Austria, which has been instrumental in the company's success. He also talks about the future plans for G.ST Antivirals and the deep scientific tech valley in Central Europe. This episode is a must-listen for anyone interested in the latest advancements in biotech and the companies leading the way in treating viral infections. 💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeGuido GualdoniChristian Soschner⏰  Timestamps:(00:00) Welcome to the Episode: Exploring the Public Funding and Eco-System in Vienna, Austria(02:35) Meet Guido Gualdoni, CEO of G.ST Antiviral(04:00) Discovering the StartUp Labs, Vienna Business Agency, AWS, FFG, Austrian Business Agency, LISA Vienna and their role in supporting startups(07:35) Exploring the Scientific Deep Tech Valley in Central Europe: Munich, Vienna, Zurich, Prague(10:15) G.ST Antiviral's 2022 Outlook(11:22) Uncovering the Innovative Technology Behind G.ST Antiviral(14:30) Guido's Biggest Takeaways from 2022(16:15) Why Optimism Bias Can be a Challenge for Entrepreneurs(18:15) Comparing the Scientific and Entrepreneurial Mindsets(24:00) The Surprising Companies that Succeeded During Economic Downturns(25:00) Examining the Latest Trends in Antiinfectious Diseases(27:45) Charting the Growth of G.ST Antiviral in 2023Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Introducing "The Year in Review Recordings", a series where we reflect on the past year and look forward to the coming one. Hosted by Christian Soschner, this podcast brings you expert speakers from previous episodes and partners of the podcast to give you an in-depth analysis of the latest advancements in their fields and an outlook for the future. This is the 6th conversation in the series.In this episode, we have Dr. Collin Y. Ewald, founder and president of the Swiss Society for Aging Research and head of the Extracellular Matrix Regeneration Laboratory at the Department of Health Sciences and Technology. Dr. Ewald has a longstanding interest in the molecular biology of healthy aging and age-related pathologies. He is a leading expert in the field and has received multiple awards, including NYAS Future Entrepreneur, recognized by the New York Academy of Sciences. He is named among the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland.We'll be discussing Dr. Ewald's recent work on the expression of extracellular matrix genes during aging, the role of the mTOR kinase in aging, and the challenges of bridging gaps in longevity research between scientific disciplines and languages. We'll also be discussing the Ewald Lab's recent work on the expression of extracellular matrix genes during aging, the role of the mTOR kinase in aging, and the challenges of bridging gaps in longevity research between scientific disciplines and languages.This episode also includes topics such as Longevity Research and Horizon Europe, How to Bridge the Gap in Horizon Programs between scientific disciplines and different languages, The 9 Hallmarks of Ageing, Solving the Clinical Trial Challenges in Longevity Research, Food Supplements for Longevity in 2023, Collin Ewald’s Spin Out Company, The 10 Simple Rules to Start a Successful Spin-Off Company, 2023 in Longevity Research – Upcoming Trends.Don't miss out on this episode of "The Year in Review Recordings," where we dive into the world of longevity research with Dr. Collin Y. Ewald and stay informed about the latest advancements in the field.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeCollin EwaldChristian Soschner⏰  Timestamps:(00:00) Intro (03:00) Welcome Note Collin Ewald(04:25) Longevity Highlights in 2022 in the Ewald Lab, ETH Zurich(07:08) Published Results of a 9 year study to understand the mTOR Kinase and its role in ageing better(08:52) Longevity Research and Horizon Europe(11:08) How to Bridge the Gap in Horizon Programs between scientific disciplines and different languages?(14:35) Highlights in the Longevity Research Area in 2022(17:08) The 9 Hallmarks of Ageing(23:17) Solving the Clinical Trial Challenges in Longevity Research(25:09) Food Supplements for Longevity in 2023(28:37) Collin Ewald’s Spin Out Company(30:37) The 10 Simple Rules to Start a Successful Spin Off Company(35:49) 2023 in Longevity Research – Upcoming TrendsSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you ready to unlock the secrets of securing funding and achieving impact in the world of European research and innovation? In this episode of our podcast, we explore the latest trends and developments in research and innovation with Kimberly Cornfield, Assistant Director (Project Development & Management) and Head of European Research and Innovation at University College London (UCL). UCL is one of the top-performing universities under the EU's Horizon 2020 program and has secured around €400 million over the last seven years to support its research and innovation activities.Kimberly and her team connect scientists and businesses around EU collaborative funding opportunities and offer a suite of support services to improve the chances of success in obtaining funding and achieving impact objectives. We'll discuss the current state of European research funding, the challenges and benefits of virtual meetings, and the future for research and innovation.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeKimberly CornfieldChristian Soschner⏰  Timestamps:(00:00) Introduction Kimberly Cornfield, UCL, and Horizon Europe(05:12) Highlights UCL and Horizon Europe Grant Funding in 2022(07:20) Advantages and Challenges – Virtual or Real Life Meetings?(09:00) Benefits of the Virtual World for UCL Research Projects(10:21) Horizon Europe(14:28) Future Trends in Research(17:28) The Rise of Social Sciences(19:28) The Relevance of Fairy Tales for Research(23:05) The Horizon Europe Work Programme for 2023(26:00) Wishes for 2023Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you ready to discover the secrets of precision nutrition and AI in the animal protein industry? Join us as we speak with the founders of BIALTEC, Mauricio Agudelo and Lina Maria Toro, to gain exclusive insights on the industry's challenges and opportunities. From tackling logistics and inflation to understanding the future of animal nutrition, this episode is packed with game-changing information you won't want to miss. Tune in now and get ready to be inspired by the innovation and vision of BIALTEC.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeChristian SoschnerMauricio AgudeloLina Toro⏰  Timestamps:(00:00) Introduction Lina Toro and Mauricio Agudelo, Founders at Bialtec(05:54) Creating Microbiomes for Animals(09:13) Big Challenges in 2022 for Bialtec – Logistics and Inflation(11:38) How did Lina Toro, CFO of Bialtec, deal with the global environment (13:31) Perceived Inflation Rate in the Bialtec Eco-System(14:19) Energy Prices in South America in 2022(16:40) Bialtec’s Activities in Europe(20:22) 3 Improvements for Founding a Company in Europe(25:28) Trends in the Animal Nutrition Industry in 2023Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are we on the brink of a technological revolution that will render content creators obsolete? Join us as we explore the rise of ChatGPT and its potential impact on the creative industry. From its capabilities as a natural language processing tool to its comparison to Bitcoin in the financial world, we'll discuss the pros and cons of this game-changing technology. Tune in to discover the truth behind the hype and what it means for content creators like you.Youtube Video⏰ Timestamps:(00:00) What Novel Technology Means(03:30) What is ChatGPT?(04:50) What Does ChatGPT Mean for the Creative Industry - ChatGPT Usecases(06:45) How ChatGPT can help in the Brainstorming/ideation Phase(10:00) Utilizing the Research Phase with ChatGPT(12:15) How can ChatGPT Help with Producing a Piece of Content?(15:38) ChatGPT as a Team for Rewriting, Editing, and Repurposing Content to Make it Native to Different Platforms(18:00) Ethical and Legal Questions🔗 Podcastlinks:EpisodesFull Youtube PlaylistFull Clips PlaylistPartner LinksChristian SoschnerSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Celebrate with us as we reach our 100th podcast episode! Join us as we look back on the past three years and revisit the 5 most downloaded episodes. From exploring the use of blockchain technology in the energy sector, to gaining valuable insights into the daily life of a VC and learning how to succeed in the competitive world of drug development, this special episode has something for everyone. Thank you for being a part of our journey and for supporting our mission to promote scientific entrepreneurs and shape a bright future for humanity. Don't miss out on this celebratory milestone episode!💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2⏰  Timestamps:(00:00) Episode 100(03:15) #5: Sascha Bucher – Forty51 Ventures(14:35) #4: Ana Trbovich – Grid Singularity(28:22) #3: Jonathan Sporn – Gilgamesh Pharmaceutical(44:35) #2: Heike Schön – Lumis International(01:04:00) #1: Alexander Belcredi – Biontech Austria(01:18:00) Outlook for 2023Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome to the third part of "This was 2022 - A Year in Review," a special edition of the Beginner's Mind Podcast. I'm your host Christian Soschner and I'm excited to be joined by Albert Missbichler, a business angel with over thirty years of experience in biochemistry and clinical diagnostics. In this episode, we'll be discussing the highlights of 2022, the differences between scientific B2B and B2C, and the challenges of translating science into simple words. We'll also be exploring the lifestyle habits and health literacy of Gen Z, as well as the crucial habits for longevity. Finally, we'll be discussing the changes in the post-pandemic conference industry and the big trends to look out for in 2023 in diagnostics. Stick around for all of this and more with Albert Missbichler on the Beginner's Mind Podcast.💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on Youtube⏰  Timestamps:(01:23) Prediction Caroline Heil for 2023(02:06) Introduction Albert Missbichler and Fianostics(03:00) Highlights Albert Missbichler in 2022 – from B2B to B2C(04:40) The  Biggest Differences between Scientific B2B and B2C(07:00) Challenges of Translating Science into Simple Words(11:30) Lifestyle Habits and Health Literacy of Gen Z(17:45) Crucial Habits for Longevity(21:15) Postpandemic Meeting Habits – What changes, what remains(25:20) Changes in the Post-Pandemic Conference Industry (28:00) Big Trends in 2023 in Diagnostics(32:00) Inoolab and FluoboltSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome to the first days of 2023! As we bid farewell to the past year, I wanted to take a moment to appreciate all the amazing conversations on my podcast over the past 12 months. From global crises to personal triumphs and failures, 2022 has been a year like no other.I covered various topics on the show, from venture capital to clinical development, psychedelics, virtual reality, and biophysics. In honor of these incredible episodes, I have decided to end the year with a compilation of the best moments from the previous 12 months.It was difficult for me to choose just five standout conversations from the many I've had, so I enlisted the help of ChatGPT to generate five numbers between 60 and 97 randomly. These five episodes are the ones I've chosen to highlight.But as we enter the new year, it’s also a time to look ahead and plan for what lies ahead. In the words of CS Lewis, "The future is something which everyone reaches at the rate of sixty minutes an hour, whatever he does, whoever he is." So grab your holiday cheer, join me as I reflect on the past year’s highlights, and look ahead to what’s in store in the new year. The clock is ticking, and the future is waiting. So, don't miss out and tune in to this YouTube video for all the exciting details!💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on Youtube⏰  Timestamps:(00:00) Welcome 2023(03:02) Episode 70: Bruno Montanari - Seroba Life Science - The Role of Venture Capital(13:00) Episode 71: Heike Schön - Lumis International - How to Rescue Clinical Trials(24:45) Episode 79: Jonathan Sporn - Gilgamesh Pharmaceuticals - Psychedelic Drugs(39:21) Episode 94: Adrian Brodesser - Somareality - Digital Diagnostics with Virtual Reality(54:22) Episode 93: Thomas Schubert - 2bind - Biophysics(01:09:00) Beginner’s Mind Podcast: Outlook to 2023The LSG2G Partners Experts in Life ScienceSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Hey everyone, this is Christian Soschner from the Beginners Mind Podcast I just wanted to take a quick moment to say thank you for following the podcast channel in 2022. Your support and engagement mean the world to me, and I am truly grateful for each and every one of you.As we head into the new year, I want to assure you that I will continue to bring you valuable content in health, healthcare, pharma, artificial intelligence, entrepreneurship, and investing. These topics are close to my heart, and I am dedicated to sharing the latest research, insights, and trends with you.But it's not just about the content but the connection. I am committed to building a community of like-minded individuals who are passionate about these topics and are eager to learn and grow together.So let's make the most of this new year. Let's decide today who we will become, what we will give, and how we will live. And let's do it with purpose, passion, and a desire to impact the world around us positively.Thank you again for your support. I look forward to continuing to bring you valuable content and being a part of this amazing community in 2023 and beyond. And before you leave for the new year's celebrations, please consider hitting the like button, leaving a comment, and following our channel. Your support helps me grow my podcast and allows me to reach more people who can benefit from my content. And if you have a moment, please consider leaving a 5-star review on Apple Podcasts and Spotify – it really helps me out. Thank you again and have a happy new year!Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome to the second part of "This was 2022 - A Year in Review," a special edition of the Beginner’s Mind Podcast as we close the year and look ahead to 2023. I'm your host Christian Soschner, and I'm excited to be joined by Caroline Heil, CEO of The New Meat Company.Caroline is a seasoned investor passionate about revolutionizing the food industry sustainably and healthily. She has worked for EY as a lawyer. She has experience advising clients on corporate aspects of M&A transactions and VC investments, with a focus on the alternative protein and meat market, food security, and sustainability.The New Meat Company is a purpose-driven impact investment company based in Berlin that invests in game-changing companies and founders disrupting the traditional meat industry with sustainable, nutritious, and tasty alternatives. They have a buy-and-build strategy, consolidating established pioneers and emerging game-changers in the alternative meat space and partnering with innovative individuals who prioritize animal welfare and reducing the ecological footprint of meat production.In this episode, Caroline will share her insights on the key trends in the food industry, the importance of proper nutrition for long-term health, and her advice for startups and scaleups seeking investment. She'll also give us a preview of what to expect in 2023 and the ideal investment opportunity for The New Meat Company.So sit back, relax, and get ready to learn from one of the top investors in the food industry as we close out the year and look ahead to the future.We have a full schedule of speakers lined up, including Kurt Höller from EIT Health, Albert Missbichler, a business angel, Lina Toro and Mauricio Agudelo from Bialtec, Kimberly Cornfield from UCL, Collin Ewald from ETH Zurich, Guido Gualdoni from G.ST Antivirals, and Thomas Schubert from 2bind.We'll be tackling questions such as:•What excited you the most in 2022?•What should change in 2023?I hope you enjoy the episode from this exciting year-in-review event.💡 LINKS TO MY OTHER CHANNELS:If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Watch in Youtube⏰  Timestamps:(00:00) Introduction Caroline Heil and the New Meat Company(05:00) Why Eating Habits are Key to a Long and Healthy Life(05:30) Getting the Nutrition Habits Right in Society has the potential to reduce healthcare expenses by 90%(08:45) The Optimal Nutrition Habits for 2023(11:50) Highlights of 2022 – Caroline Heil and The New Meat Company(12:50) The Investment Approach of The New Meat Company(14:25) Big Trends in the Food Industry in 2022(17:00) Availability of Capital in the Food Industry For Startups and Scaleups(19:30) Investment Insights in the Old Economy(20:45) Investors Advice for Startups(23:00) The Ideal Investment Opportunity for TNMC(28:15) The Big Trends in the Food Industry for 2023The LSG2G Partners Experts in Life ScienceSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome to the year-in-review podcast for 2022! As the year comes to a close, I am excited to reflect on the successes and learnings from the past 12 months and look ahead to what 2023 has in store.I have an incredible lineup of speakers from 90 previous podcast episodes; the event was live-streamed before Christmas on LinkedIn, YouTube, Twitter, and Facebook, so listeners could tune in from anywhere. To conclude the year and start into 2023, each speaker will be featured in their podcast episode.As a starter, I am thrilled to have Kurt Höller from EIT Health joining. Kurt will share his most memorable moments from 2022, his biggest successes and learnings, and his expectations for 2023. We'll also be discussing EIT Health and getting an overview of the LSG2G community.Kurt Höller is the Director of Business Creation at EIT Health, a leading healthcare initiative supporting over 750 startups and providing access to key industry players. He has a wealth of experience in healthcare, including founding and directing several companies, and a strong background in research, with a focus on health innovation.We have a full schedule of speakers lined up, including Caroline E. Heil from The New Meat Company, Albert Missbichler, a business angel, Lina Toro and Mauricio Agudelo from Bialtec, Kimberly Cornfield from UCL, Collin Ewald from ETH Zurich, Guido Gualdoni from G.ST Antivirals, and Thomas Schubert from 2bind.We'll be tackling questions such as:•What excited you the most in 2022?•What should change in 2023?I hope you enjoy the episode from this exciting year-in-review event. 💡 LINKS TO MY OTHER CHANNELS:If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Watch in Youtube⏰  Timestamps:(00:00) Intro to Year in Review, Kurt Höller, And EIT Health(03:00) Chat GPT as a helper to find questions for the podcast recording(04:30) Kurt shares his personal highlights from 2022(07:30) EIT Health in 2022(08:30) Events after the pandemic – From EIT Health Summit to Bits and Pretzels(11:00) Bits & Pretzels – The European Woodstock for Startup Entrepreneurs(12:55) Bavaria, White Sausages and Beer Habits(14:30) Kurt’s New Role as Managing Director of InvestHealth(17:30) The Venture Capital Situation in Europe in 2022(21:28) Healthtech Investment Trends in the Coming Years(23:30) Europe Becomes a Single Market for Health Apps(34:00) Estonia – Leader in Digital Adoption in Many CategoriesSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

In this episode, I unlock the untold stories behind PayPal's meteoric rise and the entrepreneurs who made it possible.The author Jimmy Soni explores the captivating story of PayPal and the entrepreneurs who helped shape Silicon Valley. From Elon Musk to Peter Thiel and many others whose stories have never been told, hear about the scrappy online payments start-up that faced fierce competition and internal strife on its journey to becoming one of the world's foremost companies. ⭐ EPISODE Links:Jimmy SoniPlease support this show by checking out the companies that make it possible.Youtube📚 Book Mentions:Jimmy Soni, The Founders Sebastian Mallaby, The Power Law 🗣️ We are talking about: • The Inspiration for writing this book• Dissecting Jimmy’s Writing Process• The Origin Story of the Paypal-Mafia• The Role of Chess and The Secret Code Hidden in the Book• Storytelling Lesson for Entrepreneurs• And much, much more📖 Memorable quotes:(20:55) “I do my books while working full-time. All my books are morning and weekend exercises.”(24:46) “I interviewed almost 300 people for this book.”(35:45) One executive said: "Calling Paypal a Mafia is an insult to the Mafia. They are far more organized than we were back then."(51:04) “David Sacks said: … as easy as email”(56:50) “The most important question for business owners: Who in the team is obsessed with how the end-user thinks and uses the product?”(01:34:30) People forget that startups are stories.⏰  Timestamps:(00:00) Intro from the Recording the Day after Thanksgiving 2022(05:55) What inspired Jimmy Soni to write the Founders?(10:00) The Entrepreneurs who Shaped Silicon Valley(16:15) Peter Thiel: How to Learn the Right Lessons in Entrepreneurship(19:24) How long does it take to write a book like the Founders?(22:15) Writing Books as a Side Hustle to writing as a profession (23:00) Exploring the Challenges of Writing Biographies of Historical and Modern Figures(25:23) Uncovering the Truth: Strategies for Sorting Through Conflicting Narratives in Interviews(27:30) The Writing Scorecard: Number of Words per Day(28:40) Uncovering the Journey from Idea to Publication: A Look at Jimmy Soni's Writing Process(30:30) Max Levchin and Tetris(32:17) The Origin Story of the Term “Paypal-Mafia”(39:00) From Beaming Money to Venmo: 20 Years of Product Development(43:00) David Sacks Halts the Progress of Groundbreaking Beaming Technology and the Birth of Digital Payment Solutions(49:40) How Paypal Found Product Market Fit(53:42) The Switch challenges from finding a solution to focusing on scaling up the solution.(58:00) The Role Chess Plays in Jimmy Soni’s Book and Paypal’s History(01:02:27) The Secret Code Hidden in the Book: Crack the Code and Get a Signed Copy(01:03:00) The Bad Bishop Situation(01:06:00) Bitcoin, the Paypal Mafia, and the New World Currency Tagline(01:15:00) Elon Musk's challenges in finding the right decisions during his early twenties.(01:20:27) Discover Jimmy's book's three most inspiring moments as he personally selects them.(01:29:30) How important are social skills in building tech companies?(01:32:00) Some Words on the Importance of Storytelling for Entrepreneurs(01:35:00) Sketching a Future of Jimmy Sonis Writing CareerSupport the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link